29.01 USD
↗ 0.09 (0.31%)AT CLOSE (11:59 AM EDT)
GH Research PLC Ordinary Shares
GHRSNASDAQ • USD
29.03
↗ 0.02 (0.07%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
29.03
↗ 0.02 (0.07%)
Market: CLOSED
GH Research PLC Ordinary Shares (GHRS) trades at $28.97 per share. Technical indicators currently signal "Strong Buy". This is driven by a bullish Golden Cross on the moving averages and bullish moving average alignment.
Technical & fundamental data as of Aug 26, 2026.
Open?$28.92
High?$29.14
Low?$28.38
Prev. Close?$28.92
Volume?145.1K
Avg. Volume?N/A
VWAP?$28.90
Bid / Ask
Bid?$28.20 × 300
Ask?$29.00 × 200
Spread?$0.80
Midpoint?$28.60
Valuation & Ratios
Market Cap?2.0B
Shares Out?68.6M
Float?36.4M
Float %?53.1%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestHigh
Short % of Float?8.63%Elevated
Short Interest?3.1M
Days to Cover?7.0
Free Float36.4M
Avg Daily Volume448.6K
Settlement Date2026-08-14